iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: https://doi.org/10.1038/sj.onc.1207817
MAGI-3 is involved in the regulation of the JNK signaling pathway as a scaffold protein for frizzled and Ltap | Oncogene
Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

MAGI-3 is involved in the regulation of the JNK signaling pathway as a scaffold protein for frizzled and Ltap

Abstract

A seven-transmembrane protein, frizzled, has been implicated in a planar cell polarity (PCP) pathway as well as the canonical Wnt signaling pathway. Although both pathways require a cytoplasmic protein, dishevelled, the molecular mechanism by which frizzled regulates intracellular signaling remains to be elucidated. In the mouse, nine frizzled family members have been identified and six of them contain a PDZ-binding motif at their carboxyl-termini. In this study, we show that a multi-PDZ containing protein, MAGI-3, specifically binds to frizzled-4 and -7. Furthermore, we also demonstrate that MAGI-3 interacts with Ltap, a mouse homolog of the Drosophila PCP protein, stbm, and that these three molecules can form a ternary complex. In epithelial cells, MAGI-3, frizzled-4, and Ltap colocalized at cell contact sites, indicating that these molecules form a physiologically significant complex. Finally, we found that MAGI-3 strongly activated JNK in conjunction with frizzled-4 and Ltap, and that this activation required the small GTPase, Rac. These results indicate that MAGI-3 functions as a scaffold protein for frizzled-4 and Ltap and regulates the JNK signaling cascade.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Adamsky K, Arnold K, Sabanay H and Peles E . (2003). J. Cell Sci., 116, 1279–1289.

  • Adler PN . (2002). Dev. Cell, 2, 525–535.

  • Bhanot P, Brink M, Samos CH, Hsieh JC, Wang Y, Macke JP, Andrew D, Nathans J and Nusse R . (1996). Nature, 382, 225–230.

  • Boutros M, Paricio N, Strutt DI and Mlodzik M . (1998). Cell, 94, 109–118.

  • Darken RS, Scola AM, Rakeman AS, Das G, Mlodzik M and Wilson PA . (2002). EMBO J., 21, 976–985.

  • Dobrosotskaya I, Guy RK and James GL . (1997). J. Biol. Chem., 272, 31589–31597.

  • Fuchs SY, Fried VA and Ronai Z . (1998). Oncogene, 17, 1483–1490.

  • Goto T and Keller R . (2002). Dev. Biol., 247, 165–181.

  • Habas R, Dawid IB and He X . (2003). Genes Dev., 17, 295–309.

  • Habas R, Kato Y and He X . (2001). Cell, 107, 843–854.

  • Heisenberg CP, Tada M, Rauch GJ, Saude L, Concha ML, Geisler R, Stemple DL, Smith JC and Wilson SW . (2000). Nature, 405, 76–81.

  • Hirao K, Hata Y, Ide N, Takeuchi M, Irie M, Yao I, Deguchi M, Toyoda A, Sudhof TC and Takai Y . (1998). J. Biol. Chem., 273, 21105–21110.

  • Hirao K, Hata Y, Yao I, Deguchi M, Kawabe H, Mizoguchi A and Takai Y . (2000). J. Biol. Chem., 275, 2966–2972.

  • Ide N, Hata Y, Nishioka H, Hirao K, Yao I, Deguchi M, Mizoguchi A, Nishimori H, Tokino T, Nakamura Y and Takai Y . (1999). Oncogene, 18, 7810–7815.

  • Ishikawa T, Tamai Y, Zorn AM, Yoshida H, Seldin MF, Nishikawa S and Taketo MM . (2001). Development, 128, 25–33.

  • Jessen JR, Topczewski J, Bingham S, Sepich DS, Marlow F, Chandrasekhar A and Solnica-Krezel L . (2002). Nat. Cell Biol., 4, 610–615.

  • Kibar Z, Vogan KJ, Groulx N, Justice MJ, Underhill DA and Gros P . (2001). Nat. Genet., 28, 251–255.

  • Korinek V, Barker N, Willert K, Molenaar M, Roose J, Wagenaar G, Markman M, Lamers W, Destree O and Clevers H . (1998). Mol. Cell. Biol., 18, 1248–1256.

  • Molenaar M, van de Wetering M, Oosterwegel M, Peterson-Maduro J, Godsave S, Korinek V, Roose J, Destree O and Clevers H . (1996). Cell, 86, 391–399.

  • Murdoch JN, Doudney K, Paternotte C, Copp AJ and Stanier P . (2001). Hum. Mol. Genet., 10, 2593–2601.

  • Nishimura W, Iizuka T, Hirabayashi S, Tanaka N and Hata Y . (2000). J. Cell Physiol., 185, 358–365.

  • Park M and Moon RT . (2002). Nat. Cell Biol., 4, 20–25.

  • Robitaille J, MacDonald ML, Kaykas A, Sheldahl LC, Zeisler J, Dube MP, Zhang LH, Singaraja RR, Guernsey DL, Zheng B, Siebert LF, Hoskin-Mott A, Trese MT, Pimstone SN, Shastry BS, Moon RT, Hayden MR, Goldberg YP and Samuels ME . (2002). Nat. Genet., 32, 326–330.

  • Shiratsuchi T, Futamura M, Oda K, Nishimori H, Nakamura Y and Tokino T . (1998). Biochem. Biophys. Res. Commun., 247, 597–604.

  • Shoji H, Tsuchida K, Kishi H, Yamakawa N, Matsuzaki T, Liu Z, Nakamura T and Sugino H . (2000). J. Biol. Chem., 275, 5485–5492.

  • Songyang Z, Fanning AS, Fu C, Xu J, Marfatia SM, Chishti AH, Crompton A, Chan AC, Anderson JM and Cantley LC . (1997). Science, 275, 73–77.

  • Taylor J, Abramova N, Charlton J and Adler PN . (1998). Genetics, 150, 199–210.

  • Wallingford JB and Harland RM . (2002). Development, 129, 5815–5825.

  • Wallingford JB, Rowning BA, Vogeli KM, Rothbacher U, Fraser SE and Harland RM . (2000). Nature, 405, 81–85.

  • Wang Y, Huso D, Cahill H, Ryugo D and Nathans J . (2001). J. Neurosci., 21, 4761–4771.

  • Wang Y, Macke JP, Abella BS, Andreasson K, Worley P, Gilbert DJ, Copeland NG, Jenkins NA and Nathans J . (1996). J. Biol. Chem., 271, 4468–4476.

  • Wang Y, Thekdi N, Smallwood PM, Macke JP and Nathans J . (2002). J. Neurosci., 22, 8563–8573.

  • Wolff T and Rubin GM . (1998). Development, 125, 1149–1159.

  • Wood JD, Yuan J, Margolis RL, Colomer V, Duan K, Kushi J, Kaminsky Z, Kleiderlein JJ, Sharp AH and Ross CA . (1998). Mol. Cell. Neurosci., 11, 149–160.

  • Wu Y, Dowbenko D, Spencer S, Laura R, Lee J, Gu Q and Lasky LA . (2000). J. Biol. Chem., 275, 21477–21485.

  • Yamanaka H, Moriguchi T, Masuyama N, Kusakabe M, Hanafusa H, Takada R, Takada S and Nishida E . (2002). EMBO Rep., 3, 69–75.

  • Yao R, Maeda T, Takada S and Noda T . (2001). Biochem. Biophys. Res. Commun., 286, 771–778.

Download references

Acknowledgements

We thank Dr E Peles for MAGI-3 cDNA and antibody. We also thank Drs A Hall, J Nathans, T Sudo, Y Kasuya, A Kikuchi, and J Miyazaki for plasmids. This work was supported by a Grant-Aid for Scientific Research from the Ministry on Education, Sports, Science, and Culture of Japan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tetsuo Noda.

Additional information

Supplementary Information accompanies the paper on Oncogene website (http://www.nature.com/onc)

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yao, R., Natsume, Y. & Noda, T. MAGI-3 is involved in the regulation of the JNK signaling pathway as a scaffold protein for frizzled and Ltap. Oncogene 23, 6023–6030 (2004). https://doi.org/10.1038/sj.onc.1207817

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207817

Keywords

This article is cited by

Search

Quick links